Cite
MLA Citation
L. Hoffmann et al.. “Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours.” Radiotherapy and oncology, vol. 171, 2022, pp. 53–61. http://access.bl.uk/ark:/81055/vdc_100156441472.0x000041